Education
About Us
Working with TipRanks
Follow Us
Artrya Limited (AU:AYA)
ASX:AYA
AYA Stock Chart & Stats
AU$3.72
-AU$0.03(-4.17%)
At close: 4:00 PM EST
AU$3.72
-AU$0.03(-4.17%)
Day’s Range― - ―
52-Week RangeAU$0.45 - AU$4.29
Previous CloseN/A
Volume107.30K
Average Volume (3M)878.02K
Market Cap
AU$626.01M
Enterprise ValueAU$63.75M
Total Cash (Recent Filing)AU$11.33M
Total Debt (Recent Filing)AU$624.00K
Price to Earnings (P/E)―
Beta1.94
Next Earnings
Feb 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding158,084,010
10 Day Avg. Volume1,092,517
30 Day Avg. Volume878,024
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)3.12
Price to Sales (P/S)2373.98
P/FCF Ratio-4.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Artrya Limited News
AYA FAQ
What was Artrya Limited’s price range in the past 12 months?
Artrya Limited lowest share price was AU$0.45 and its highest was AU$4.29 in the past 12 months.
What is Artrya Limited’s market cap?
Artrya Limited’s market cap is AU$626.01M.
When is Artrya Limited’s upcoming earnings report date?
Artrya Limited’s upcoming earnings report date is Feb 24, 2026 which is in 66 days.
How were Artrya Limited’s earnings last quarter?
Artrya Limited released its earnings results on Aug 20, 2025. The company reported -AU$0.086 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.086.
Is Artrya Limited overvalued?
According to Wall Street analysts Artrya Limited’s price is currently Overvalued.
Does Artrya Limited pay dividends?
Artrya Limited does not currently pay dividends.
What is Artrya Limited’s EPS estimate?
Artrya Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Artrya Limited have?
Artrya Limited has 158,084,010 shares outstanding.
What happened to Artrya Limited’s price movement after its last earnings report?
Artrya Limited reported an EPS of -AU$0.086 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.985%.
Which hedge fund is a major shareholder of Artrya Limited?
Currently, no hedge funds are holding shares in AU:AYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Artrya Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:AYA Sentiment 100%
Sector Average 68%
Sector Average 68%
Technicals
SMA
Positive
20 days / 200 days
Momentum
781.57%
12-Months-Change
Fundamentals
Return on Equity
-86.14%
Trailing 12-Months
Asset Growth
24.53%
Trailing 12-Months
Company Description
Artrya Limited
Artrya Limited (AYA) is an innovative medical technology company specializing in the development of artificial intelligence (AI) software solutions aimed at revolutionizing the diagnosis and treatment of coronary artery disease. Operating within the healthcare and technology sectors, the company's core product, Salix, leverages advanced AI algorithms to analyze cardiac CT scans, providing clinicians with detailed insights into coronary artery health, thus enhancing diagnostic accuracy and patient outcomes.
Technical Analysis
Resonance Health Ltd
―
Beamtree Holdings Ltd
―
MedAdvisor Limited
―
Singular Health Group Ltd
―
HitIQ Limited
―